- Telehealth Visits
- Insurance plan information
Thomas T. Reid, MD, MA
Hospice and Palliative Care • Hospital Medicine- Telehealth Visits
- Insurance plan information
Thomas T. Reid, MD, MA
Hospice and Palliative Care • Hospital Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Thomas Reid provides palliative care consultations for hospitalized patients. He cares for adults in the UCSF Moffitt-Long Medical Service and children at UCSF Benioff Children's Hospitals.
Reid's research focuses on primary and specialty palliative care education.
Reid completed his medical degree, a residency in internal medicine and pediatrics, and a fellowship in hospice and palliative medicine at the University of Rochester School of Medicine and Dentistry. He also has a master's degree in medical sciences from Boston University.
Reid is a member of the American Academy of Hospice and Palliative Medicine.
Education & training
Board certification
- Hospice & Palliative Medicine, American Board of IM/Hospice & Palliative Medicine
Degree
- MD, University of Rochester Schl of Medicine/Dentistry
My expertise
Specialties
- Hospice and Palliative Care
- Hospital Medicine
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.